NORDIX DNA ApS: Financial statements 2022
CVR: 36908130
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
NORDIX DNA ApS (CVR 36908130) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 755,244 and a net result of DKK 74,000 compared with DKK 14,097 the year before. That is an increase of 246.5% compared with the year before. Equity in the 2022 report amounted to DKK 113,923. The solvency ratio was 7.3%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 755,244
- Profit/Loss
- DKK 74,000
- Equity
- DKK 113,923
- Total Assets
- DKK 1,568,449
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 755 t. | 74 t. | 114 t. | 2 |
| 2021 | - | 218 t. | 14 t. | 40 t. | 1 |
| 2020 | - | -4 t. | -7 t. | -14 t. | 1 |
| 2019 | - | -1 t. | -1 t. | -7 t. | 1 |
| 2018 | - | -2 t. | -2 t. | -6 t. | 1 |
Official annual report
Keep an eye on NORDIX DNA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NORDIX DNA ApS has published its annual report for 2021. Gross profit came to DKK 217,962, and the net result was DKK 14,097.
About NORDIX DNA ApS
NORDIX DNA ApS is a Danish company of the type Anpartsselskab based in Frederikshavn, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named NORDIX DNA IVS and FAB.DK IVS. The management consists of Casper Holm Mulberg. The company is owned by NORDIX HOLDING ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -9,011 and a net result of DKK -9,011 compared with DKK -98,799 the year before. Equity in the 2025 report amounted to DKK -1,465.